- Home
- ASA vs ASTH Comparison
ASA vs ASTH Comparison
Compare ASA & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASA | ASTH |
|---|---|---|
| Founded | 1958 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Professional Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 905.1M | 1.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ASA | ASTH |
|---|---|---|
| Price | $53.07 | $22.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $43.00 |
| AVG Volume (30 Days) | 65.0K | ★ 598.3K |
| Earning Date | 01-27-2026 | 11-06-2025 |
| Dividend Yield | ★ 0.11% | N/A |
| EPS Growth | ★ 335.96 | N/A |
| EPS | ★ 19.90 | 0.20 |
| Revenue | $3,982,215.00 | ★ $2,896,452,000.00 |
| Revenue This Year | N/A | $58.37 |
| Revenue Next Year | N/A | $25.48 |
| P/E Ratio | ★ $2.66 | $112.97 |
| Revenue Growth | ★ 99.75 | 68.17 |
| 52 Week Low | $19.37 | $20.12 |
| 52 Week High | $54.69 | $43.70 |
Technical Indicators
Market Signals| Indicator | ASA | ASTH |
|---|---|---|
| Relative Strength Index (RSI) | 65.54 | 36.38 |
| Support Level | $51.94 | $22.62 |
| Resistance Level | $54.03 | $23.67 |
| Average True Range (ATR) | 1.80 | 1.13 |
| MACD | 0.44 | 0.26 |
| Stochastic Oscillator | 81.07 | 53.95 |
Price Performance
Historical ComparisonAbout ASA ASA Gold and Precious Metals Limited
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.